News & Events

Six sites are now collaborating with the Deutsches Krebsforschungszentrum (German Cancer Research Center) in the National Center for Tumor Diseases (NCT). In Berlin, a central partner is the Charité – Universitätsmedizin Berlin, in close cooperation with the Berlin Institute of Health at the Charité (BIH) and the Max Delbrück Center.

Muscle cells are very good at repairing damage. But if this fails, stem cells step in to regenerate the tissue. Carmen Birchmeier investigates the molecular signaling pathways that underlie these and other vital mechanisms.

Antonia Klein joined the Max Delbrück Center in 2019. She works in the Technology Transfer department and supports scientists in patenting of their inventions, further development and commercialization of technologies. Her reading tip takes you to the many different corners of the world.

Researchers suspect that neurodegenerative diseases occur when messenger RNA (mRNA) goes astray in the neuron. With a new method, Marina Chekulaeva is able to identify “zipcodes” that assign a destination to mRNAs. She has now presented her method in the journal Nature Neuroscience.

Combining single-cell data with a self-learning algorithm reveals how structural changes in chromosomes can trigger cancer. This new method could pave the way for personalized cancer treatments, writes a team led by Ashley Sanders in “Nature Biotechnology”.

Leif S. Ludwig, a researcher at the Max Delbrück Center and the Berlin Institute of Health at Charité (BIH), will receive the Paul Ehrlich and Ludwig Darmstaedter Young Investigator Award 2023 for a new method to analyze the formation of blood cells, as the Scientific Council of the Paul Ehrlich Foundation announced today.

Organoids have to be fed and cared for continuously so that they can mature. So far, it is mostly a manual process – not suitable for industrial drug screening. Now, the European Research Council (ERC) has awarded Mina Gouti a Proof of Concept Grant to tackle scalability and reproducibility.

A group of international researchers – among them Stephan Mathas from the ECRC – has found that changing a single segment of the genome causes a previously unknown immunodeficiency in humans. The paper, which appears in Science Immunology, reports the discovery of a point mutation in the transcription factor IRF4.

Digitalization is in full swing, and the Max Delbrück Center is no exception. Arno Edinger and his team in the IT Department are responsible for implementing this process throughout the research center. The aim is not to digitalize employees out of existence, but rather to free them from annoying routine tasks that waste their time.